Manufacturer High Quality CAS 13311-84-7 Raw Material Flutamide

• Powder: Yes
• Customized: Customized
• Certification: GMP
• Suitable for: Elderly
• State: Solid
• Purity: >96%
• Model NO.: API
• CAS No.: 13311-84-7
• Appearance: Light Yellow Powder
• Type: Nonsteroidal Antiandrogens Raw Material
• Applicaion: Treatment of Prostate Cancer and Prostatic Hypert
• MOQ: 25kgs
• Sample: Availble
• Package: 25kg Per Drum
• Transport Package: Barrel
• Specification: 25KG
• Trademark: OEM/ODM
• Origin: Shangqiu, Henan, China
• Production Capacity: 5t/ Per Month

Product Description

Product Details

Flutamide cas 1311-84-7 is a non-steroidal androgen antagonist, belonging to the acylanilides, and is the first-line treatment for prostate cancer. It was first designed and synthesized by Schering-Plough in the United States. Due to flutamide itself does not have any hormonal activity, it has a good effect on treating prostate diseases, and has no effect on the blood vessels of the heart Chemicalbook, and can maintain the patient's sexual function. It has gradually become a commonly used drug for the treatment of prostate cancer and benign prostatic hyperplasia in European and American countries. It can be used for androgen-related non-prostate diseases, and there have been a lot of studies in the world. In addition, flutamide has a low incidence of adverse reactions and can be well tolerated by patients in low-dose multiple oral administrations, so it can be widely used.

Appearance: Light Yellow  Powder


Indication:   Treatment of prostate cancer and prostatic hypertrophy





Function:

As non-steroidal androgen antagonists, flutamide is used in the treatment of prostate cancer and prostatic hypertrophy and combined with luteinizing-releasing hormone-Liampu, which can treat advanced prostate cancer and prostatic hypertrophy.

Package

Packing: Barrel
NW: 25KG
GW: 27.5KG

Invetory






FAQ
1.Q: Is it API?
   A: Yes, certainly.

2.Q: Can you show your COA?
   A: Yes, if you need.

3.Q: Can I order now?
   A: Yes, of couse.